The stake comes alongside an agreement for Vancouver, Washington-based Absci to use AMD chips and software to power its drug ...
Grifols has filed for US approval of a new drug for rare bleeding disorder acquired fibrinogen deficiency (AFD), which ...
GSK is reportedly in late-stage negotiations about a $1 billion deal to acquire IDRx and its experimental targeted therapy ...
Novo Nordisk has almost doubled the scale of an R&D alliance with Valo Health – a specialist in applying artificial ...
Belgian biotech Galapagos is mixing things up again via a plan to split in two, separating its innovative medicines and cell ...